Plasminogen Activator Inhibitor-1 Deficiency Has Renal Benefits but Some Adverse Systemic Consequences in Diabetic Mice

Publisher： Karger

E-ISSN： 1660-2129|104|1|e23-e34

ISSN： 1660-2129

Source： Nephron Experimental Nephrology, Vol.104, Iss.1, 2006-05, pp. : e23-e34

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of dsRNA on Mesangial Cell Synthesis of Plasminogen Activator Inhibitor Type 1 and Tissue Plasminogen Activator

By  

Nephron Experimental Nephrology, Vol. 113, Iss. 2, 2009-07 ,pp. : e57-e65

Karger

Access to resources Recommend Favorite

Renal Tubulointerstitial Fibrosis in OVE26 Type 1 Diabetic Mice

By  

Nephron Experimental Nephrology, Vol. 111, Iss. 1, 2008-12 ,pp. : e11-e19

Karger

Access to resources Recommend Favorite

Renal Gene Expression in Embryonic and Newborn Diabetic Mice

By  

Nephron Experimental Nephrology, Vol. 10, Iss. 2, 2002-04 ,pp. : 130-138

Karger

Access to resources Recommend Favorite

Renal Tissue Factor Expression Is Increased in Streptozotocin-Induced Diabetic Mice

By  

Nephron Experimental Nephrology, Vol. 101, Iss. 3, 2005-07 ,pp. : e86-e94

Karger

Access to resources Recommend Favorite

Regulation of Tissue Plasminogen Activator Production in Cultured Human Fetal Mesangial Cells

By  

Nephron Experimental Nephrology, Vol. 6, Iss. 6, 1998-11 ,pp. : 508-513

Karger

Access to resources Recommend Favorite